Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent

• TAKESHITA Akihiro

  Department of Internal Medicine, Hamamatsu University School of Medicine

• SHINJO Kaori

  Department of Internal Medicine, Hamamatsu University School of Medicine

• NAITO Kensuke

  Department of Internal Medicine, Hamamatsu University School of Medicine

• MATSUI Hirotaka

  Department of Internal Medicine, Hamamatsu University School of Medicine

• SAHARA Naohi

  Department of Internal Medicine, Hamamatsu University School of Medicine

• SHIGENO Kazuyuki

  Department of Internal Medicine, Hamamatsu University School of Medicine

• SUZUMURA Taeko

  Department of Transfusion Medicine, Hamamatsu University School of Medicine

• HORII Toshinobu

  Department of Laboratory Medicine, Hamamatsu University School of Medicine

• SHIRAI Naohito

  Department of Laboratory Medicine, Hamamatsu University School of Medicine

• MAEKAWA Masato

  Department of Laboratory Medicine, Hamamatsu University School of Medicine

• YADA Yoshihiro

  Department of Hematology, Osaka City General Hospital

• TESHIMA Hirofumi

  Department of Hematology, Osaka City General Hospital

• TAKEUCHI Jin

  Department of Hematology and Rheumatology, Nihon University School of Medicine

• OHNISHI Kazunori

  Department of Internal Medicine, Hamamatsu University School of Medicine

• OHNO Ryuzo

  Aichi Cancer Center

Journal

• Int J Hematol

  Int J Hematol 82 (5), 445-448, 2005-12-25

Keywords

• Acute promyelocytic leukemia
• Gemtuzumab ozogamicin (Mylotarg)
• All-trans retinoic acid
• Arsenic trioxide
• Drug resistance

Details

• CRID: 1570291225327409792
• NII Article ID: 10016917120
• NII Book ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2006179907
• Text Lang: en
• Data Source:
  • CiNii Articles